Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

BECKLEY PSYTECH LIMITED

Home Clinical Trial Sponsors and OrganizationsBECKLEY PSYTECH LIMITED

BECKLEY PSYTECH LIMITED

Beckley Park, Oxford, United Kingdom

Share to Twitter Share to Facebook Share to LinkedIn Share to Reddit

Clinical Trials

6

0 active

Approvals

0

Total approvals

Agencies

0

Regulatory bodies

Founded

N/A

Overview

Trial Phase Distribution

Phase

Trials

Share

Phase 1

3

50.0%

Phase 2

3

50.0%

Trial Status Distribution

Completed

4

66.7%

Recruiting

1

16.7%

Terminated

1

16.7%

Clinical Trials

Trials sponsored by this organization (6)

BPL-003 Efficacy and Safety in Treatment Resistant Depression

Sep 2023196 participants

An Open-Label, Single Dose Study in Patients With Alcohol Use Disorder

May 202313 participants

An Open-Label Study to Evaluate the Safety, Tolerability and Pharmacodynamics of BPL-003 in Patients With Treatment Resistant Depression

Feb 202372 participants

Single Ascending Dose Study With BPL-003 in Healthy Subjects

Feb 202262 participants

Single Ascending Dose Study With 5-MeO-DMT in Healthy Subjects

Sep 202136 participants

Phase 1b Study in Patients With Short-Lasting Unilateral Neuralgiform Headache Attacks (SUNHA)

Aug 20214 participants

Approvals

No approval data available

News

No news articles found

On this page

Overview
Clinical Trials6
Approvals
News

Back to Organizations